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Abstract
Inflammation is a physiological response to tissue trauma or infection, but leukocytes, which are the effector cells of the
inflammatory process, have powerful tissue remodelling capabilities. Thus, to ensure their precise localisation, passage of
leukocytes from the blood into inflamed tissue is tightly regulated. Recruitment of blood borne neutrophils to the tissue
stroma occurs during early inflammation. In this process, peptide agonists of the chemokine family are assumed to provide
a chemotactic stimulus capable of supporting the migration of neutrophils across vascular endothelial cells, through the
basement membrane of the vessel wall, and out into the tissue stroma. Here, we show that, although an initial chemokine
stimulus is essential for the recruitment of flowing neutrophils by endothelial cells stimulated with the inflammatory
cytokine tumour necrosis factor-a, transit of the endothelial monolayer is regulated by an additional and downstream
stimulus. This signal is supplied by the metabolism of the omega-6-polyunsaturated fatty acid (n-6-PUFA), arachidonic acid,
into the eicosanoid prostaglandin-D2 (PGD2) by cyclooxygenase (COX) enzymes. This new step in the neutrophil recruitment
process was revealed when the dietary n-3-PUFA, eicosapentaenoic acid (EPA), was utilised as an alternative substrate for
COX enzymes, leading to the generation of PGD3. This alternative series eicosanoid inhibited the migration of neutrophils
across endothelial cells by antagonising the PGD2 receptor. Here, we describe a new step in the neutrophil recruitment
process that relies upon a lipid-mediated signal to regulate the migration of neutrophils across endothelial cells. PGD2
signalling is subordinate to the chemokine-mediated activation of neutrophils, but without the sequential delivery of this
signal, neutrophils fail to penetrate the endothelial cell monolayer. Importantly, the ability of the dietary n-3-PUFA, EPA, to
inhibit this process not only revealed an unsuspected level of regulation in the migration of inflammatory leukocytes, it also
contributes to our understanding of the interactions of this bioactive lipid with the inflammatory system. Moreover, it
indicates the potential for novel therapeutics that target the inflammatory system with greater affinity and/or specificity
than supplementing the diet with n-3-PUFAs.
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Introduction
In vertebrates, tissue trauma or infection causes the rapid
initiation of an inflammatory reaction. The early phase of this
phylactic response results in the localised recruitment of cells of the
innate immune system from the blood, a tissue infiltrate that is
dominated by neutrophils. The molecular processes that support
the initial interactions between blood-borne neutrophils and the
endothelial cells lining postcapillary venules (the site in the blood
vasculature where leukocytes are recruited during inflammation)
are well described (see Figure 1 for a schematic representation of
the steps in the neutrophil recruitment process). In response to the
localised production of inflammatory mediators, such as the
cytokine tumour necrosis factor-a (TNF), activated endothelial
cells decorate themselves with specialised adhesion receptors of the
selectin family [1–3]. Due to their ability to rapidly form strong
but short-lived bonds with carbohydrate counter-ligands on the
neutrophil surface, E- and P-selectin are capable of tethering
neutrophils from rapidly flowing blood [4]. The sequential
formation and dissolution of selectin bonds also support a
characteristic and dynamic form of adhesion, referred to as rolling
[5]. Rolling adhesion does not require neutrophil activation.
However, neutrophil migration through the vessel wall and into
the inflamed tissue is dependent upon the receipt of an activating
stimulus [5,6]. We have previously shown that endothelial cells can
present peptide agonists of the CXC-chemokine family to rolling
neutrophils and thus stabilise adhesion [7,8]. Ligation of the
neutrophil CXC-Receptor-2 (CXCR2) by these agents is essential
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for activation of the b2-intergrin adhesion receptors and the
reorganisation of the actin cytoskeleton that support transendothe-
lial cell migration [8]. Here, we show that in the presence of an
antibody that blocks chemokine interactions with CXCR2,
neutrophils roll on the endothelial cell surface indefinitely
(Figure 2), demonstrating that a chemokine signal is essential for
neutrophil activation on TNF-stimulated endothelial cells. How-
ever, the removal of this primary activating stimulus provides no
information on the requirement for additional, downstream
signals, which might coordinate transit of the vessel wall and
onward migration into stromal tissues.
Results/Discussion
EPA Released from Endothelial Cell Membrane
Phospholipids Inhibits the Recruitment of Neutrophils
Dietary omega-3 polyunsaturated fatty acids (n-3-PUFAs) have
anti-inflammatory properties. For example, their inclusion in the
diet in the form of n-3-PUFA–rich fish oil reduces the symptoms of
disease as well as the use of nonsteroidal anti-inflammatory drugs in
arthritis patients with severe inflammatory joint disease [9]. In
addition, dietary n-3-PUFAs may offer protection against vascular
pathology associated with atherosclerosis, having been reported to
be efficacious in epidemiological studies [10]. By modulating
inflammation within the artery wall, n-3-PUFAS also alter the
cellular and the structural composition of advanced atherosclerotic
plaques in a manner that could reduce the incidence of plaque
rupture or ulceration, a process that precedes tissue infarction (e.g.,
heart attack or stroke) [11]. Despite these documented anti-
inflammatory benefits, the mode(s) of interaction of these lipids
with the immune and inflammatory systems are not well
understood. When we supplemented endothelial cell culture
medium with the major n-3 -PUFA found in dietary fish oil
supplements, eicosapentaenoic acid (EPA; 20:5n-3), it was incorpo-
Figure 1. Steps in the process of neutrophil recruitment. Step 1: Neutrophils are captured from flow and tether and roll on tumour necrosis
factor-a (TNF)-stimulated endothelial cells. Step 2: Neutrophils are then activated by the action of CXC-chemokines on the chemokine receptor,
CXCR2, a process resulting in the activation of neutrophil b2-integrins. Step 3: b2-integrins engage counter receptors on the endothelial cell surface,
and the neutrophil becomes stationary. Step 4: Prostaglandin-D2 (PGD2), generated by the action of cyclooxygenase enzymes on the n-6-PUFA
arachidonic acid (AA), binds the PGD2 receptor, DP-1. DP-1 generates signals that stabilise neutrophil adhesion, induce neutrophil shape change, and
support the process of transmigration across the endothelial cell monolayer. Step 5: If the endothelial cells have been supplemented with the n-3-
PUFA, eicosapentaenoic acid (EPA), the alternative series prostanoid, PGD3, is generated, and this antagonises PGD2-mediated neutrophil responses.
doi:10.1371/journal.pbio.1000177.g001
Author Summary
Inflammation is a physiological response to tissue trauma
or infection. Neutrophils, which circulate in the blood
stream, are the first inflammatory cells to be recruited to a
site of tissue inflammation. In response to recruitment
signals provided by chemotactic peptides called chemo-
kines, neutrophils traverse the endothelial cell lining of
blood vessels. This process involves a multistep cascade of
neutrophil adhesion and activation events on the endo-
thelial barrier. While investigating the anti-inflammatory
functions of the omega-3 fatty acid , EPA, which is found,
for instance, in dietary fish oil, we identified an additional
unexpected lipid-derived signal that is essential for
neutrophil migration across the endothelium. Our exper-
iments show that a chemokine delivered the first signal
needed to bind neutrophils firmly to the endothelial
surface. However, in order to traverse the endothelium, a
subsequent signal delivered by prostaglandin-D2 (PGD2), a
lipid derived from the omega-6 fatty acid arachidonic acid,
was essential. When EPA, was introduced into the
experiment, it was used to form PGD3. This alternative
lipid blocked interactions between PGD2 and its receptor
on neutrophils, preventing the process of migration across
the endothelial barrier. Thus, we reveal a new step in the
recruitment of neutrophils during inflammation, and a
novel anti-inflammatory mechanism of action of dietary
EPA.
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rated into cellular phospholipids so that upon withdrawal of the free
fatty acid from the culture medium, a pool of esterified EPA
remained localised within endothelial cell membranes (Figure 3A
and 3B). After withdrawal of free fatty acid and stimulation with
TNF, EPA-treated cells were able to support similar levels of
neutrophil adhesion to those that had received no lipid supplement
(Figure 4A). However, detailed analysis showed that the behaviour
of neutrophils on the two populations of endothelial cells was very
different. In response to TNF, but in the absence of EPA, a small
population of adherent neutrophils (,20%) rolled throughout the
duration of a flow adhesion assay (Figure 4B). The remaining cells
became activated on the endothelial cell surface, and this population
of neutrophils became progressively smaller as cells migrated across
the endothelial cell monolayer (Figure 4B). In contrast, when
endothelial cells had been treated with EPA prior to TNF
stimulation, there was a marked reduction in the number of cells
undergoing transendothelial cell migration (Figure 4B). This was
reduced at the earliest time point and did not increase over the
duration of the experiment. Interestingly however, many of the cells
that did become activated on the surface of endothelial cells reverted
to a rolling form of adhesion (Figure 4B), implying that after the
receipt of an initial chemokine stimulus, a second signal was
required to allow prolonged adhesion and migration across the
endothelial cell monolayer. Experiments using different concentra-
tions of EPA showed that these inhibitory effects were evident at
concentrations as low as 50 nM (Figure 4C).
EPA Does Not Inhibit the Expression of Inflammatory
Genes in Endothelial Cells
To define the molecular mechanisms underlying these obser-
vations, we tested two prevalent hypotheses. The first, predicated
on the observation that n-3-PUFAs regulate the transcription of
endothelial cell inflammatory genes by down-regulating the
activity of the nuclear factor-kB, predicts changes in the levels of
adhesion receptor and chemokine expression after supplementa-
tion with EPA [12–14]. However, previous studies have
investigated the regulation of gene expression in the presence of
up to 100 mM of n-3-PUFAs, whereas physiological blood plasma
levels of free fatty acid are of the order of 1 mM [15], a level that
can be increased several fold upon supplementation. Using 5 mM
EPA as an approximation of the highest concentration achievable
in vivo, we did not see changes in the expression of endothelial cell
adhesion molecules when assessed for RNA transcripts or protein
expression (Figure 5 and Table 1). Neither was there any alteration
in the levels of cytokines and chemokines secreted by endothelial
cells (Table 2). Thus, in this model, we were able to discount the
gene regulation hypothesis.
The Anti-Inflammatory Effects of EPA Supplementation
Require the Metabolic Activity of Cyclooxygenase
Enzymes
The second hypothesis proposes that upon endothelial cell
activation, EPA may compete with the n-6-PUFA arachidonic
acid (AA; 20:4n-6) for cyclooxygenase enzymes (COX1 and
COX2) after both fatty acids are liberated from membrane
phospholipids by endogenous phospholipases [16]. Ordinarily, AA
is metabolised by COX into 2-series endoperoxides, with
downstream synthases converting these into the biologically active
2-series prostanoids [17]. However, when utilised as a COX
substrate, the metabolism of EPA generates alternative 3-series
prostanoids [16]. The 2-series prostanoids generated by COX
activity are known to regulate aspects of the inflammatory
response. For example, in the COX2 knockout mouse, neutrophil
recruitment is dramatically reduced upon ischaemia and
Figure 2. Chemokine signalling through CXCR2 is essential for neutrophil activation on TNF-stimulated endothelial cells. Using a
flow-based adhesion assay, neutrophils isolated from whole blood were perfused across endothelial cells. Neutrophils were recruited to endothelial
cells treated with TNF, but did not adhere to unstimulated endothelium. Detailed analysis of neutrophil behaviour showed that on TNF-stimulated
endothelial cells, the majority of recruited cells transmigrated across the monolayer. When neutrophils were treated with anti-CXCR2, but not anti-
CXCR1, neutrophil activation was inhibited so that nearly all of the recruited neutrophils rolled indefinitely on the monolayer and could not migrate;
data are mean6SEM of four experiments **p,0.01 for comparison by paired t-test of neutrophil behaviour on TNF stimulated endothelial cells in the
presence or absence of anti-CXCR2.
doi:10.1371/journal.pbio.1000177.g002
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Figure 3. The effects of EPA supplementation on the fatty acid content of endothelial cell phospholoipds. (A and B) The concentration
of EPA in membrane phospholipids was increased after supplementation of culture medium with EPA for 24 h. Error bars indicate SEM. AA,
arachidonic acid; FA, fatty acid; PA, palmitic acid; SA, stearic acid.
doi:10.1371/journal.pbio.1000177.g003
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reperfusion-induced injury of the liver when compared to wild-
type control animals [18]. In a murine model of lipopolysaccha-
ride-induced lung inflammation, inhibitors of COX function
(indomethacin and aspirin) modestly increased neutrophil recruit-
ment [19]. Conversely in vitro, inhibition of COX function by
aspirin can inhibit neutrophil migration [20] while having no
effect on the levels of neutrophil adhesion to the endothelial cell
monolayer [21]. Moreover, in murine models of acute and chronic
inflammation, a reduction in PGE2 production by genetic deletion
of its membrane-bound synthase, moderates the formation of
inflammation-associated granulation tissue and angiogenesis, as
well as decreasing the nociception of pain, indicating that PGE2 is
proinflammatory in these models [22]. PGD2 also appears to have
proinflammatory functions, as overexpression of the synthase
generating this prostanoid increases production of inflammatory
cytokines and chemokines, leading to exaggerated levels of
eosinophil and lymphocyte recruitment [23], a mechanism that
operates through the PGD2 receptor DP-2. In contrast, in acute
peritoneal inflammation, knockout of PGD2 synthase increased
inflammatory cytokine production and retarded the rate of
inflammatory resolution by a mechanism that operated through
the DP-1 receptor [24]. Thus, PGD2 appears to have pro- or anti-
inflammatory capabilities depending on the nature of the
inflammatory insult. The inflammatory activity of the equivalent
Figure 4. The effects of EPA supplementation on the adhesive behaviour of neutrophils. (A) EPA supplementation did not affect the
number of neutrophils initially adhering to endothelial cells from flow. (B) However, the time course of neutrophil behaviour on TNF-stimulated
endothelial cells showed that EPA supplementation drastically altered neutrophil behaviour. Thus, the number of activated and surface adherent
neutrophils decreased with time in the presence or absence of EPA. However, on endothelium that had not been supplemented with EPA, this was
because neutrophils transmigrated across the monolayer, whereas on EPA-supplemented endothelium this was because activated cells reverted back
to a rolling form of adhesion. ANOVA showed that there was a significant effect of treatment (i.e., 6EPA) on the percentage of cells that were rolling,
surface adherent, or transmigrated (p,0.01). In addition, there was a significant effect of time on each form of behaviour for the EPA-treated cells
(p,0.0520.01). Bonferroni tests showed significant differences at specific time points as marked; **p,0.01. (C) Inhibition of neutrophil
transmigration was evident at levels of EPA supplementation as low as 50 nM. Data are mean6SEM of five experiments. ANOVA showed significant
effects of treatment (p,0.05); *p,0.05 compared to untreated control by Dunnett’s test. Error bars indicate SEM.
doi:10.1371/journal.pbio.1000177.g004
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3-series prostanoids is not known. Here, by introducing a panel of
COX inhibitors into endothelial cell cultures at the same time as
they were activated with TNF, the effects of EPA supplementation
could be replicated, with neutrophil transmigration being
dramatically inhibited (Figure 6). Moreover, adding a molecular
excess of AA to EPA-supplemented endothelial cells at the point of
TNF activation could reverse the blockade of migration (Figure 6).
Taken together, these data imply that a COX-derived product of
AA is required for the transmigration of neutrophils across TNF-
stimulated endothelial cells, and that in the presence of EPA, this
pathway is efficiently antagonised.
Prostaglandin D2 Is Required for Neutrophil Migration
across Endothelial Cells Stimulated with TNF-a
Endothelial cells generate COX products constitutively. For
example, prostacyclin (PGI2) and prostaglandin D2 (PGD2) are
endothelial cell-derived vasoactive prostanoids that are also
involved in the regulation of haemostasis, being antagonists of
platelet activation [17,25]. These prostanoids are difficult to
measure in the systemic blood, as they have reported half-lives in
plasma that are measured in minutes [26,27]. However, the
constitutive nature of their production is demonstrated by the
presence in urine and body fluids of their downstream metabolic
products, PGF1a and delta-PGJ2, respectively [28,29].
Prostanoids have a documented ability to regulate the migration
of a number of leukocyte subsets. For example, PGD2 induces
chemotaxis of eosinophils and T-lymphocytes [30] in vitro.
Interestingly, the migration of monocyte-derived migratory
dendritic cells (DCs) may be tightly regulated by interplay between
different prostanoids. Thus, the ability of these cells to traffic out of
tissue into lymph nodes via the lymphatic circulation is dependent
upon the presence of PGE2 as a differentiation signal [31–34]. In
this context PGE2 promotes the function (but not the expression)
of the chemokine receptor CCR7, so that DCs efficiently respond
to the chemokines CCL19 and CCL21. Importantly, a number of
Figure 5. The effect of EPA on TNF-induced surface adhesion molecule expression. The expression of (A) E-selectin and (B) VCAM-1 was
measured by ELISA in TNF-stimulated endothelial cells that were either unsupplemented or supplemented with EPA. Data are mean6SEM of seven
experiments. ANOVA showed that there was a significant effect of the dose of TNF (p,0.01), but not of EPA, on the expression of both receptors.
doi:10.1371/journal.pbio.1000177.g005
Table 1. Effect of EPA treatment on mRNA expression of
endothelial cell adhesion molecules and chemokines induced
by TNF.
Analyte TNF-a TNF-a+5 mM EPA Statistics
E-selectin 2,0466780 1,8906854 NS
ICAM-1 55613 61621 NS
VCAM-1 52616 64626 NS
TNF-a 16611 17613 NS
MCP-1 562. 963 NS
CXCL1 160.05 160.04 NS
CXCL2 863 762 NS
Endothelial cells were cultured alone or in the presence of 5 mM EPA for 24 h
and stimulated with 100 U/ml TNF for the final 4 h. Data are presented as the
fold change compared to the level of mRNA in unstimulated endothelial cells.
There was no significant effect of EPA treatment on the gene expression profile
of TNF-stimulated endothelial cells. Data are 6SEM of four experiments.
NS, not significant.
doi:10.1371/journal.pbio.1000177.t001
Table 2. Effect of EPA treatment of endothelial cells on the
TNF-a-induced secretion of cytokines and chemokines.
Analyte TNF-a TNF-a+0.5 mM EPA TNF-a+5 mM EPA Statistics
IL-6 204619 15668 180623 NS
IL-8 5,695652 5,3026561 5,3846891 NS
IFN-c 360.5 2.060.2 260.2 NS
CXCL10 112617 100629 136615 NS
GM-CSF 862 661 761 NS
CCL2 8,2986854 6,0006342 7,4116420 NS
CCL3 236697 230621 2656130 NS
CCL5 386632 4066128 6406121 NS
TNF-a 358678 225636 252631 NS
TNF-b 460.3 361 460.5 NS
Endothelial cells were cultured alone or in the presence of 5 mM EPA 24 h and
stimulated with 100 U/ml TNF for the final 4 h. Culture supernatants were
collected and assayed by Luminex for cytokines and chemokines. There was no
significant effect of EPA treatment on analyte expression compared to TNF-
stimulated endothelial cells. Data are presented as picograms per milliliter, and
are mean6SEM of four experiments.
NS, not significant.
doi:10.1371/journal.pbio.1000177.t002
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studies have shown that the presence of PGD2 can in turn inhibit
the ability of DCs to migrate out of the lungs or the skin during an
inflammatory response, although the molecular mechanism by
which this inhibition is achieved remains undescribed [35,36].
As prostanoids are well documented to regulate leukocyte
migration [37], we tested the hypothesis that PGD2 was the
endothelial cell-derived agent providing the stimulus for neutrophil
migration across the monolayer. We established a population of
surface adherent neutrophils on TNF-treated endothelial cells
supplemented with EPA and perfused synthetic PGD2 across the
endothelial cells and neutrophils to see whether this would
reintroduce transmigration. The provision of exogenous PGD2
but not PGD3 (which could be derived from EPA), fully restored
the ability of neutrophils to cross the endothelial cell monolayer
(Figure 7A). Prostaglandin D2 has two receptors. Chemoattrac-
tant-receptor homologous molecule expressed on Th2 cells
receptor (CRTH2 or DP-2) is not expressed in neutrophils [35],
whereas the DP-1 receptor has been reported in these cells [38].
Here, neutrophils perfused across TNF-stimulated endothelial cells
in the presence of a DP-1 receptor antagonist (BW868C) showed a
greatly diminished efficiency of endothelial cell transmigration
(Figure 7B). Conversely, the transmigration of neutrophils was re-
established on EPA-supplemented endothelial cells when a
synthetic DP-1 receptor agonist (BW245C) was perfused across
cells adherent to the surface of the monolayer (Figure 7C).
Importantly, we could demonstrate that PGD2 was operating
directly on the neutrophils, because when these cells were
harvested after migrating across a TNF-stimulated endothelial
cells they had up-regulated CD11b (the alpha subunit of the b2
integrin CD11b/CD18 that is required for efficient neutrophil
transmigration) and proteolytically shed L-selectin (Figure 8).
However, neutrophils harvested from the surface of EPA-treated
endothelial cells did not shed L-selectin or up-regulate CD11b.
Thus, in this assay system, the delivery of a PGD2-mediated signal
to the neutrophils was necessary for full cellular activation and
efficient transendothelial migration.
PGD3 Generated from EPA Antagonises the PGD2-
Mediated Migration of Neutrophils across Endothelial
Cells
Taken together, these data show that PGD2 operates through
the neutrophil DP-1 receptor to provide a signal that is essential
for transendothelial cell migration. Moreover, the ability of
neutrophils to respond to this signal is abolished when endothelial
cells are preloaded with EPA from which PGD3 is generated. This
implies that PGD3 may be an effective antagonist of the DP-1
receptor. To test this hypothesis, we perfused neutrophils across
TNF-stimulated endothelial cells in the presence of exogenous
PGD3. Neutrophil transmigration was inhibited in a dose-
dependent manner by PGD3, showing that in the presence of
endogenously generated PGD2 it could effectively antagonise this
process (Figure 7D). Importantly, we were able to show that cells
supplemented with EPA-generated an increased amount of PGD3
(Figure 7E).
The absolute levels of PGD2 and PGD3 that are generated in
our assay system, and thus the ratio of their abundance, are not
easily assessed. The levels of PGD2 measured as an endothelial cell
releasate were at the limits of detection (Table 3), presumably due
to the short half-life of this prostanoid under physiological
conditions; however, significant levels of PGD3 were assayed
upon EPA supplementation, and concentrations in the order of 5–
10 nM had accumulated over the 24 h of the EPA supplemen-
tation period. The half-life of PGD3 in serum or albumin-
containing medium has not been reported to our knowledge; thus
it is not clear whether the measurements made here report the true
levels of PGD3 production, or if metabolic degradation of this
prostanoid renders these measurements underestimates. Irrespec-
tive of this, our experiments utilising synthetic PGD2 demonstrate
that concentrations on the order of 1 nM were sufficient to fully
recapitulate the process of migration on EPA-supplemented
endothelial cells, and when using PGD3 as an antagonist of
TNF-induced transmigration marked effects were evident at 10–
100 pM. Thus, the measurable levels of PGD3 that we report
Figure 6. A cyclooxygenase (COX)-derived eicosanoid is required for neutrophil transmigration across TNF-stimulated endothelial
cells. (A) Inhibition of COX-1 (SC-560), COX-2 (NS-398), or both (indomethacin) caused inhibition of neutrophil transmigration, *p,0.05 by t-test. (B)
Addition of AA to EPA-supplemented endothelial cells during the period of TNF stimulation restored neutrophil transmigration. All data are
mean6SEM of four experiments. ANOVA showed significant effects of treatments in both (A and B) (p,0.01). In (A), Dunnett test showed significant
effects of individual treatments compared to untreated control, *p,0.05. In (B), Dunnett’s test showed significant difference between EPA-treated
and untreated control (**p,0.01), but not between AA+EPA and control.
doi:10.1371/journal.pbio.1000177.g006
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Figure 7. The role of AA- and EPA-derived eicosanoids in neutrophil transmigration. (A) When PDG2 was perfused across a population of
neutrophils adherent to EPA-treated endothelial cells, neutrophil transmigration was restored. However, PGD3 had no significant effect on neutrophil
behaviour. All data are mean6SEM of four experiments. ANOVA showed significant effect of treatment on transmigration. *p,0.05 compared to EPA-
supplemented endothelial cells in the absence of PGD2 by Dunnett test. (B) The DP1 receptor antagonist BW868c dose-dependently inhibited
neutrophil transmigration on TNF-stimulated endothelial cells. All data are mean6SEM of five experiments; ANOVA showed a significant effect of
BW868c concentration (p,0.01). (C) Perfusion of the DP-1 receptor agonist, BW245C, across neutrophils adherent to EPA-supplemented endothelial
cells restored neutrophil migration to control levels. Data are mean6SEM of five experiments. ANOVA showed a significant effect of treatment on
transmigration. **p,0.01 compared to EPA-supplemented endothelial cells in the absence of BW868C by Dunnett test. (D) Neutrophils perfused
across TNF-stimulated endothelial cells in the presence of PGD3 showed a significantly reduced ability to migrate across the monolayer. Data are
mean6SEM of three experiments; ANOVA showed a significant effect of PGD3 concentration on transmigration (p,0.01). (E) The levels of PGD3
released from endothelial cells are increased after EPA supplementation. Data are mean6SEM of three experiments. ANOVA showed a significant
effect of treatment (p,0.05). **p,0.01 for PGD3 production compared to endothelial cells activated with TNF without EPA supplementation by
Dunnett’s test.
doi:10.1371/journal.pbio.1000177.g007
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would certainly be sufficient to effectively antagonise the
transmigration of neutrophils in our experimental model.
Conclusions
Our study demonstrates a hitherto unknown regulatory step in
the recruitment of neutrophils by cytokine-stimulated endothelial
cells (refer to Figure 1 to see how this new step fits with the known
regulatory mechanisms of neutrophil recruitment). After initial
tethering by selectin molecules, a chemokine signal induces arrest
of the cell on the endothelial cell surface. However, the chemokine
signal is not sufficient to support transmigration across the
endothelial cell monolayer, and the arachidonic acid-derived
prostanoid, PGD2, is an essential downstream regulator of this
process. PGD2 operates through the DP-1 receptor and this signal
can be effectively antagonised by PGD3 which is generated from
EPA released by the action of phospholipase enzymes on the
phospholipids of EPA supplemented cells. Not only does this study
reveal a new step in the recruitment of neutrophil recruitment
during inflammation, it also reveals a novel anti-inflammatory
mechanism of action of the dietary n-3-PUFA, EPA.
Materials and Methods
Cell Culture and Neutrophil Isolation
Endothelial cells (EC) were isolated and cultured, as previously
described [39], with or without 0–5 mM EPA (Sigma) for 24 h.
TNF-a (100 U/ml; R&D systems) was added to the EC for the
final 4 h of culture. In some experiments, EC were treated with
100 U/ml TNF-a in the presence of 10 mM indomethacin or
0.1 mM SC-560 or 1 mM NS-398 (Sigma). In the AA reconstitu-
tion experiments, 5 mM AA (Sigma) was added to the culture
medium simultaneously with TNF-a.
Blood from healthy adult volunteers was collected into tubes
coated with EDTA (1.6 mg/ml), and neutrophils were separated
using 2-step density gradients of Histopaque 1119 and 1077
(Sigma), as previously described [40]. After washing in 0.15% BSA
in PBS, cells were counted using a Coulter Multisizer (Coulter
Electronics), and neutrophils, which were .95% pure, were
resuspended at a concentration of 16106/ml in PBS/Alb with
calcium and magnesium.
RNA Extraction and Real-Time PCR
mRNA was isolated from EC using the Qiagen RNEasy Mini
Kit 50 (Qiagen) following the manufacturer’s instructions. Real-
time PCR (RT-PCR) was performed using QuantiTect probe
RT-PCR kit according to the manufacturer’s instructions
(Qiagen). Primers were purchased from Applied Biosystems.
The expression of each target gene was normalised to b-actin
Figure 8. The effect of adhesion on the expression of L-selectin
and CD11b on neutrophils. Neutrophils that were freshly isolated,
migrated across endothelial cells stimulated with TNF or adherent to the
surface of EPA-supplemented endothelial cells (EC) activated with TNF
were harvested and the expression of (A) CD11b or (B) L-selectin (CD62L)
assessed by flow cytometry. Data are mean6SEM of four experiments;
ANOVA showed significant effect of treatments in (A) (p,0.01) and (B)
(p,0.05). In (A and B), Dunnett’s test showed significant difference
between 2EPA and freshly isolated cells (*p,0.01 and *p,0.05,
respectively), but not between +EPA and freshly isolated cells.
doi:10.1371/journal.pbio.1000177.g008
Table 3. Analysis of eicosanoids by liquid chromatography tandem mass spectrometry.
Treatment 5-HETE 8-HETE 11-HETE 12-HETE 15-HETE PGD2/PGE2
Untreated 3.861.5 0.560.2 1.060.4 2.761.0 1.460.5 0.07460.12
100 U/ml TNF-a 2.660.6 0.460.1 0.760.1 2.060.4 1.060.2 0.06660.01
100 U/ml TNF-a+5 mM EPA 2.360.6 0.360.1 0.760.2 1.960.5 1.060.2 0.06460.01
HETEs and prostanoids were analysed by reverse-phase liquid chromatography tandem mass spectrometry in unstimulated and TNF-stimulated endothelial cells in the
presence or absence of EPA. There was no significant difference in concentrations of HETEs or prostanoid secretion under any treatment (statistical analysis by ANOVA).
Data are presented as nanograms per sample and are mean6SEM of three experiments.
doi:10.1371/journal.pbio.1000177.t003
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expression, and the data presented represent fold change
compared to untreated EC.
Luminex for Secreted Cytokines and Chemokines
Supernatants were collected from EC that had been incubated
with 0–5 mM EPA for 24 h and had 100 U/ml TNF added to the
culture for the final 4 h of culture. The Luminex kit was purchased
from Upstate/Chemicon, and the experiment performed to the
manufacturer’s instructions. Data were collected and analysed
from the samples using a Luminex100 machine (Luminex).
Flow-Based Adhesion Assay
Glass capillaries (microslides) containing treated EC mono-
layers were incorporated into a flow-based adhesion assay as
described [39]. Briefly, microslides were attached to cell and fluid
reservoirs by silicon tubing at one end and to a withdrawal
syringe pump at the other end. After mounting on the stage of a
phase contrast microscope, EC were washed for 2 min with PBS
containing 0.15% BSA. Neutrophils were then perfused (16106/
ml) at 0.1 Pa for 4 min, followed by 15 min of wash. Video
images were recorded throughout the experiment and neutrophil
behaviour analysed offline using Image Pro software (Image-Pro
Plus). In some experiments, neutrophils were perfused across
EPA- and TNF-treated EC, allowed to adhere, and subsequently
perfused with 1 nM PGD2 or 1 nM PGD3 (both from Cayman
Chemicals). Alternatively, neutrophils were treated with BW868c
(Cayman Chemicals), a DP1 receptor antagonist, for 10 min
prior to perfusion over TNF-a-stimulated EC. Neutrophils were
also treated with the DP1 receptor agonist BW245c (Cayman
Chemicals) prior to perfusion over EPA- and TNF-a-treated EC.
Neutrophils were also treated with 0–1 nM PGD3, immediately
prior to perfusion across TNF-stimulated EC. In all experiments,
lipid reagents, agonists, and antagonists were stored in 100%
ethanol under nitrogen gas. Once diluted, the medium contained
,0.01% ethanol. All controls contained equivalent concentra-
tions of ethanol.
Analysis of EPA Incorporation into Cellular Phospholipids
First-passage confluent EC were treated with 5 mM of EPA for
24 h. EC were removed from the plastic culture dish by scraping
and stored in 0.88% KCl solution at 220uC until analysis. Total
lipid was extracted with chloroform:methanol (2:1, v/v) containing
butylated hydroxytoluene (50 mg/l) as antioxidant. Fatty acids were
subsequently hydrolysed from the lipid and simultaneously
methylated by incubation with methylation reagent (methanol
containing 2% v/v H2SO4) at 50uC for 2 h. Fatty acid methyl esters
were separated and identified using a Hewlett Packard 6890 gas
chromatograph (Hewlett Packard) fitted with a 30 mm632 mm
BPX 70 capillary column, film thickness 0.25 mm. Helium, at the
initial flow rate of 1.0 ml/min, was used as the carrier gas. Injector
and detector temperatures were 275uC, and the column oven
temperature was maintained at 170uC for 12 min after sample
injection. The oven temperature was programmed to increase from
170 to 210uC at 5uC/min. Fatty acid methyl esters were identified
by comparison with authentic standards. Peak areas were quantified
using ChemStation software (Hewlett Packard). Each fatty acid was
expressed as weight percent of total fatty acids present.
Eicosanoid Extraction and Reverse-Phase High-
Performance Liquid Chromatography Analysis
Eicosanoids were extracted from control EC using C18 Sep-Pak
cartridges (Waters). Briefly, cartridges were conditioned with 5 ml
of high-performance liquid chromatography (HPLC)-grade
MeOH and rinsed twice with water. Reactions were terminated
with addition of 100% ice-cold MeOH, containing 2 ng of internal
standard PGE2-d4. Sample volume was adjusted to 10% MeOH
with water and applied to the column. The column was rinsed
with water and the sample eluted with 2 ml of MeOH. Nitrogen
gas was used to dry the sample, which was resuspended in 100 ml
of MeOH and stored at 280uC until analysis.
Prostaglandin Quantitation using Liquid
Chromatography Tandem Mass Spectrometry
Prostaglandins were separated on a C18 ODS2, 5 mm, 15064.6-
mm column (Waters) using a gradient of 50%–90% B over 20 min
(A, water:acetonitrile:acetic acid, 75:25:0.1; B, methanol:acetonitri-
le:acetic acid, 60:40:0.1) at 1 ml/min. Products were quantitated by
directing the HPLC output directly into the electrospray source of a
Q-Trap mass spectrometer (Applied Biosystems 4000 Q-Trap)
operating in the negative mode (24,500 V). Individual prostaglan-
dins were monitored in the Multiple Reaction Monitoring (MRM)
mode using specific parent to daughter transitions of m/z 349–269 for
PGD3 with collision energies of226 V. Products were identified and
quantified with reference to the appropriate standards run in parallel
under the same conditions, with 2 ng of PGE2-d4 (m/z 355–275)
added as an internal standard.
Analysis of Neutrophil Adhesion Molecule Expression by
Flow Cytometry
Neutrophils for analysis were isolated from whole blood as
described above. Control cells were stained for flow cytometry
directly after isolation. Cells rolling on EPA-treated endothelial
cells in microslides were harvested by elution with 0.02% EDTA
after 4 min of neutrophil perfusion and 11 min of wash buffer
perfusion (totalling 15 min of contact with endothelial cells). In
order to harvest neutrophils that had migrated across endothelial
cells, endothelium was cultured on 1.5 mg/ml type I collagen gels
(Becton Dickinson). After endothelial cell stimulation with TNF for
4 h, neutrophils were added for 15 min. Surface-adherent cells
were washed off with 0.02% EDTA, and the gel was dissolved
using type VII collagenase (Sigma). Neutrophils were harvested
from the dissolved gel by centrifugation. All neutrophil populations
were stained for surface expression of CD11b (PE-conjugated,
clone 2LPM19c, 2 mg/ml; DAKO) or CD62L (FITC-conjugated,
clone Dreg56,10 mg/ml, Beckton Dickinson). Expression was
analysed by flow cytometry using a DAKO CyAn, and data
analysed using Summit software (Becton Dickinson). Data are
expressed as mean fluorescent intensity.
Statistical Analysis
Data were analysed using Prism software (GraphPad software).
Results are presented as means6standard error of the mean
(SEM). Comparisons between individual treatments were by
paired t-test where appropriate. ANOVA was performed to assess
the effect of EPA concentration on PMN transmigration.
Significant findings were investigated further using Bonferroni
multiple comparison test or Dunnett’s test.
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